Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oxaliplatin chitosan nanoparticle and application thereof

A technology of chitosan nanoparticles and oxaliplatin is applied in the directions of medical preparations without active ingredients, medical preparations containing active ingredients, digestive system, etc., which can solve the problem of chitosan nanoparticles without oxaliplatin. and other problems, to achieve the effects of cheap raw materials, high encapsulation rate and simple process

Inactive Publication Date: 2013-06-26
HANGZHOU NORMAL UNIVERSITY
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Currently there are no reports and patents on oxaliplatin chitosan nanoparticles

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oxaliplatin chitosan nanoparticle and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Example 1 Oxaliplatin chitosan nanoparticles 1

[0020] 40 mg chitosan (molecular weight 1 x 10 4 ) was dissolved in 13 mL acetic acid aqueous solution (pH=4.0), weighed 5.7 mg sodium tripolyphosphate (TPP) was dissolved in 5 mL water, 10 mg oxaliplatin was dissolved in 2 mL water, and the TPP solution was mixed with oxaliplatin After the platinum solution was mixed, it was slowly added to the chitosan solution, and magnetically stirred at room temperature for 30 min to obtain a colloidal solution of chitosan nanoparticles. Using a tangential flow membrane bag (molecular weight 10K) for ultrafiltration, using water as a replacement liquid, repeating ultrafiltration, and adjusting the volume of the suspension to obtain oxaliplatin-chitosan nanoparticles. Its average particle size is 59 nm, and the encapsulation efficiency is 86.54%.

Embodiment 2

[0021] Embodiment 2 Oxaliplatin chitosan nanoparticles 2

[0022] 40 mg chitosan (molecular weight 1 x 10 4 ) was dissolved in 13 mL acetic acid aqueous solution (pH=4.0), 8 mg sodium tripolyphosphate (TPP) was weighed and dissolved in 5 mL water, 10 mg oxaliplatin was dissolved in 2 mL water, and TPP solution was mixed with oxaliplatin After the platinum solution was mixed, it was slowly added to the chitosan solution, and magnetically stirred at room temperature for 30 min to obtain a colloidal solution of chitosan nanoparticles. Dilute to 20 mL with water, perform ultrafiltration with a tangential flow membrane bag (molecular weight: 10K), use water as a replacement liquid, repeat ultrafiltration, and adjust the volume of the suspension to obtain oxaliplatin-chitosan nanoparticles. Its average particle size is 88nm, and the encapsulation efficiency is 82.13%.

Embodiment 3

[0023] Embodiment 3 Oxaliplatin chitosan nanoparticles 3

[0024] 40 mg chitosan (molecular weight 1 x 10 4 ) was dissolved in 13 mL acetic acid aqueous solution (pH=4.0), 13.3 mg sodium tripolyphosphate (TPP) was weighed and dissolved in 5 mL water, 10 mg oxaliplatin was dissolved in 2 mL water, and TPP solution was mixed with oxaliplatin After the platinum solution was mixed, it was slowly added to the chitosan solution, and magnetically stirred at room temperature for 30 min to obtain a colloidal solution of chitosan nanoparticles. Dilute to 20 mL with water, perform ultrafiltration with a tangential flow membrane bag (molecular weight: 10K), use water as a replacement liquid, repeat ultrafiltration, and adjust the volume of the suspension to obtain oxaliplatin-chitosan nanoparticles. Its average particle size is 116 nm, and the encapsulation efficiency is 83.37%.

[0025] The particle size figure of embodiment 4 experimental example 1 gained oxaliplatin chitosan nanopart...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses an oxaliplatin chitosan nanoparticle and an application thereof. The preparation materials of the oxaliplatin chitosan nanoparticle comprise oxaliplatin, chitosan, sodium tripolyphosphate and an acetic acid aqueous solution. The oxaliplatin chitosan nanoparticle disclosed by the invention can be applied to preparing a drug for treating gastrointestinal tumors. Compared with the prior art, the oxaliplatin chitosan nanoparticle disclosed by the invention is small in grain size, high in encapsulation efficiency, low in material price and simpler in process.

Description

(1) Technical field [0001] The invention relates to the field of drug nanoparticles, in particular to an oxaliplatin-chitosan nanoparticle and an application thereof. (2) Background technology [0002] Oxaliplatin is a third-generation platinum-based anticancer drug. In 2004, the FDA approved oxaliplatin for injection in combination with 5-fluorouracil and folinic acid for the first-line treatment of advanced colorectal cancer. Oxaliplatin preparations currently on the market include water injection and freeze-dried powder injection. Oxaliplatin has a significant effect on advanced colorectal cancer, and can also treat other gastrointestinal tumors such as gastric cancer. However, with the extensive clinical application of oxaliplatin, its adverse reactions have been continuously discovered and reported. Neurotoxicity, gastrointestinal reactions, and bone marrow suppression are common adverse reactions. [0003] Nanoparticles are a kind of drug delivery system with good ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/14A61K31/282A61K31/194A61K47/36A61P35/00A61P1/00
Inventor 曾昭武王俊洁肖人钟谢恬王小丽周广林刘星言
Owner HANGZHOU NORMAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com